We are testing a new vaccine-based immunotherapy for patients with pancreatic cancer. This study aims to see if it can enhance the effectiveness of current treatments.
Health conditions and diseases that the clinical trial is designed to study and treat.
Pancreatic cancer is a type of cancer that begins in the pancreas, often presenting as pancreatic adenocarcinoma. It can be classified into resectable, non-resectable, and metastatic forms, with symptoms that may include abdominal pain, weight loss, jaundice, and digestive issues.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
